Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:00:34.118Z.
Consensus retrieved: 2026-10-06T08:22:34.916Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:00:34.118Z.
Quote observation: 2026-10-06T17:58:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e8c4723d74b6f0443862f85907ca9030ea6941843cb736177163438a313e1ca1
FORWARD PE RATIO
N/A
Alpha Cognition Inc
Market Cap
$138.93M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Alpha Cognition Inc (ACOG) | $138.93M | N/A |
| Immuneering Corporation (IMRX)vs › | $140.31M | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $140.52M | 7.00 |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $141.00M | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.66M | N/A |
| Freenome, Inc. (FRNM)vs › | $135.33M | N/A |
| Protara Therapeutics, Inc. (TARA)vs › | $142.76M | N/A |
| Organigram Global Inc. (OGI)vs › | $134.99M | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in USD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
